It might be prudent to make a point of collecting a little more cash in the near future, and worry a little less about growth.

Pfizer (PFE), in collaboration with Bristol Myers Squibb, has introduced a direct-to-patient option for Eliquis®, potentially ...

Following in the footsteps of other pharmaceutical companies, Bristol Myers Squibb and Pfizer are offering Eliquis for cash-paying patients at a discount of 40% off the list price.

Shares are down in the year to date and 20% off their 52-week high, but analysts see 30% upside ahead for Pfizer.

TOKYO -- Roughly 2.5 million doses of oral COVID-19 medication bought by the Japanese government during the pandemic expired and were disposed of by the end of February, Nikkei has learned.

A Wall Street maxim states, “Twenty percent of investors who want to make money are in stocks, while the other 80 percent who ...

Encounter-level factors played a key role in limiting outpatient COVID-19 treatment for Black and Latino patients.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

Investors love dividend stocks, especially those with dependable yields of 7% or higher, because they offer a significant income stream and have substantial total return potential. Total return ...

PFE trades above its 50-day average for over a month, signaling bullish momentum despite COVID revenue declines and patent risks.